Tag: Cancer: Breast
Multigene Test IDs More at Risk for Hereditary Breast/Ovarian CA
Testing for mutations other than BRCA1/2 in HBOC may change clinical management for women, families
Diastolic Dysfunction Common After Anthracycline Chemo
BMI and age independently linked to diastolic dysfunction after anthracycline chemotherapy
Hypofractionated Breast Irradiation = Reduced Toxicity
Two studies show benefits for hypofractionated vs conventionally fractionated whole-breast irradiation
No Increased Risk for One-and-Done Breast Reconstruction
Single-stage implant procedures after mastectomy may be a good option for selected patients
Test Set Performance Indicators Correlate Well With Clinical Audit
In mammography, JAFROC and location sensitivity correlate with several clinical audit parameters
Generic Meds Boost Survival in Some Early Breast Cancers
Researchers found benefit from aromatase inhibitors and bisphosphonates
Nodal Radiation Doesn’t Impact Early Breast Cancer Survival
Researchers find it lowers chances of recurrence, but does not boost overall survival
ASCO Guidelines: Biomarker Use in Metastatic Breast CA Treatment
Hormone receptor status of metastases should be used to guide tx if supported by clinical scenario
Breast CA Survivors Gain More Weight Than Cancer-Free Peers
Survivors, especially those who received chemo, gained more weight versus cancer-free women
Regular Mammograms May Lead to Widespread Overdiagnosis
No significant difference in breast cancer deaths for counties with higher screening, detection rates
